ScandiDos decides on new share issue
The issue comprises a maximum of 14,252,771 shares at a subscription price of SEK 0.90 per share.
See the latest news and media coverage for ScandiDos. We track all announcements, press releases, and industry mentions in real time, all in one place.
Radiotherapy quality assurance solutions provider
scandidos.comLast updated
In short: ScandiDos appointed Anders Murman as acting CEO, launched the Delta4 SRS Pro, and reported financial losses due to project delays.
The issue comprises a maximum of 14,252,771 shares at a subscription price of SEK 0.90 per share.
Net sales SEK 14.2 million and EBITDA SEK 0.8 million in Q4. Full year shows net sales SEK 54.2 million.
The issue of SEK 12.8 million will finance marketing and regulatory costs. The net proceeds are estimated at SEK 12.3 million.
Gustaf Piehl steps down after six years. The Board starts recruiting a permanent CEO immediately.
ScandiDos AB announces that Gustaf Piehl is stepping down as Chief Executive Officer at his own request. The Board has appointed Anders Murman as Acting...
Scandios reduces its turnover and turns to loss, the company reports. The radiation therapy company believes that the lower quarterly result is a consequence of...
Scandidos, which offers software and hardware solutions for patient quality assurance in radiation therapy, had an EBITDA result of 0.2 million kronor (-4.9) during the first quarter, May-July, in the...
It is Universitätsklinik für Strahlentherapie in Innsbruck, which has been a customer since 2009, that now chooses to invest in Delta4 Discover. - Universitätsklinik für Strahlentherapie...
Track ScandiDos and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.